Vijaykrishnan Ganesan

With over 18 years of experience in the pharmaceutical industry, I have expertise in Pharmacovigilance - Processing & Reporting of Individual Case Safety & Aggregate Reports, Safety Database Customizations & User Acceptance Testing/Validations, Literature Review, Business process excellence and robotic process automations, project management, patient centricity, audit and inspection readiness. As the Director of Pharmacovigilance Safety Operations at Parexel, I lead a team of Healthcare/Life science professionals in ensuring the safety and quality of clinical trials and post marketing programs. Holding an EMBA in Pharma Management from the Indian Institute of Pharmaceutical Management and a Post Graduate Program in Business Analytics and Business Intelligence from The University of Texas at Austin - Red McCombs School of Business, passionate about building First Time Quality and applying data-driven insights to improve patient outcomes and enhance operational efficiency. Additionally, enjoys sharing knowledge and skills through training, mentorship, and thought leadership forums.

• Beyond Leadership Award, Parexel, 12/24, For contributions towards India Strategic Initiatives
• Hall of Fame, Indian Society for Clinical Research, 02/24, Recipient of Hall of Fame (HOF) Award for significant contributions towards ISCR Pharmacovigilance Council in India
• Hall of Fame, Indian Society for Clinical Research, 02/23, Recipient of Hall of Fame (HOF) Award for significant contributions towards ISCR Pharmacovigilance Council in India

Active collaboration with study teams to ensure the project deliverables are delivered within the budget and allocated hours are spent judiciously to ensure all the billable tasks are completed within the stipulated deadlines.

Helped to identify inefficiencies to remove redundancies like hand-offs, multiple QCs, checklist preparation etc. to improve overall process efficiency and promote First Time Quality (FTQ) by automating certain manual processes.

Active role in the conceptualization and implementation of Strategic Operational Data Delivery (SODD) to review and refine dashboard wireframes and data source prioritization for data lake ingestion.

Supported increase the EBITDA & profitability of the company by implementing cost-saving measures (for e.g Advance Pricing Agreement).

Passionate in exploring new revenue streams and leveraging emerging technologies like Generative AI for risk management strategies for complex drugs and rare diseases.